Bigul

Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

Stay order by High Court of Telangana on insolvency proceedings and deferment of 1st meeting of COC scheduled to be held today
03-06-2022
Bigul

Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Dated 30.05.2022

Approved the Audited (standalone and consolidated) financials for the half year and year ended 31.03.2022
30-05-2022
Bigul

Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Audited Financials (Standalone And Consolidated) For The Half Year Ended 31.03.2022

Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve the Audited Financials (Standalone and Consolidated) for the half year ended 31.03.2022
23-05-2022
Bigul

Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal

Admission of claim and Initiation of CIRP Process under IBC - In the matter of NCLT application under section 9 of Insolvency and Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 filed against the Company
29-04-2022
Bigul

Vanta Bioscience Ltd - 540729 - Certificate Under Reg 40(9) For The Year Ended 31.03.2022

Certificate under Reg 40(9) for the year ended 31.03.2022
21-04-2022
Bigul

Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Reg 7(3) For The Year Ended 31.03.2022

Compliance Certificate under Reg 7(3) for the year ended 31.03.2022
20-04-2022
Next Page
Close

Let's Open Free Demat Account